Diagnosis and treatment of intravascular lymphomatosis.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 10714664)

Published in Arch Neurol on March 01, 2000

Authors

T P Baumann1, N Hurwitz, E Karamitopolou-Diamantis, A Probst, R Herrmann, A J Steck

Author Affiliations

1: Department of Neurology, University Hospital, Basel, Switzerland.

Articles by these authors

(truncated to the top 100)

Intensive hospital monitoring of adverse reactions to drugs. Br Med J (1969) 12.09

Complete sequence analysis of the genome of the bacterium Mycoplasma pneumoniae. Nucleic Acids Res (1996) 10.46

Predisposing factors in adverse reactions to drugs. Br Med J (1969) 5.80

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc Natl Acad Sci U S A (1997) 5.66

Conversion of bacteriophage fd into an efficient single-stranded DNA vector system. Mol Gen Genet (1980) 3.57

Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell (2001) 3.29

Primary gastrointestinal non-Hodgkin's lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 3.22

Transposition of a DNA sequence determining kanamycin resistance into the single-stranded genome of bacteriophage fd. Mol Gen Genet (1978) 3.19

Re-annotating the Mycoplasma pneumoniae genome sequence: adding value, function and reading frames. Nucleic Acids Res (2000) 2.79

5-Fluorouracil in colorectal cancer, a never ending story. Ann Oncol (1996) 2.69

Deoxyribonucleic acid replication in vitro. J Mol Biol (1972) 2.64

Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain. J Neurosci (2000) 2.49

Gene dosage by quantitative real-time PCR. Biotechniques (1999) 2.45

Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet (2001) 2.45

Neuron loss in APP transgenic mice. Nature (1998) 2.38

Isolation and characterization of thermosensitive Escherichia coli mutants defective in deoxyribonucleic acid replication. J Bacteriol (1973) 2.38

Comparative analysis of the genomes of the bacteria Mycoplasma pneumoniae and Mycoplasma genitalium. Nucleic Acids Res (1997) 2.28

Analysis of three different repeated DNA elements present in the P1 operon of Mycoplasma pneumoniae: size, number and distribution on the genome. Nucleic Acids Res (1990) 2.21

Admissions to hospital due to drugs. Br Med J (1969) 2.17

Association of microglia with amyloid plaques in brains of APP23 transgenic mice. Am J Pathol (1999) 2.10

Repetitive DNA sequences in Mycoplasma pneumoniae. Nucleic Acids Res (1988) 2.09

Neuropathology in mice expressing human alpha-synuclein. J Neurosci (2000) 2.06

A randomized study of high-dose cytarabine in induction in acute myeloid leukemia. Blood (1996) 2.06

Quality of life as subjective experience: reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy. Swiss Group for Clinical Cancer Research (SAKK) Ann Oncol (1999) 1.98

Physical mapping of the Mycoplasma pneumoniae genome. Nucleic Acids Res (1988) 1.92

Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol (2006) 1.87

Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer (1980) 1.82

Alzheimer's paired helical filaments share epitopes with neurofilament side arms. EMBO J (1986) 1.81

Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study. Ann Oncol (1998) 1.80

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). Ann Oncol (2000) 1.79

Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform. EMBO J (1995) 1.77

Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Mult Scler (2006) 1.70

Cloning of the complete Mycoplasma pneumoniae genome. Nucleic Acids Res (1989) 1.70

Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci U S A (1998) 1.68

Prospective randomised trial of amifostine cytoprotection in myeloma patients undergoing high-dose melphalan conditioned autologous stem cell transplantation. Bone Marrow Transplant (2005) 1.64

Overview of monoclonal antibodies in cancer therapy: present and promise. Crit Rev Oncol Hematol (2005) 1.63

Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res (1983) 1.60

Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet (2004) 1.56

Transposon mutagenesis reinforces the correlation between Mycoplasma pneumoniae cytoskeletal protein HMW2 and cytadherence. J Bacteriol (1997) 1.56

The proline-rich P65 protein of Mycoplasma pneumoniae is a component of the Triton X-100-insoluble fraction and exhibits size polymorphism in the strains M129 and FH. J Bacteriol (1995) 1.54

Life-threatening orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol (2005) 1.53

Isolated internal ophthalmoplegia associated with IgG anti-GQ1b antibody. Neurology (1998) 1.52

Identification and characterization of hitherto unknown Mycoplasma pneumoniae proteins. Mol Microbiol (1994) 1.51

Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study. Eur J Nucl Med Mol Imaging (2002) 1.50

The JAK2 V617F mutation is detectable in granulocyte populations at greater than two copies per cell among individuals with myeloproliferative disorders. Leukemia (2007) 1.47

[Lambert-Eaton myasthenic syndrome. Physiopathological aspects and therapeutic modalities]. Rev Neurol (Paris) (1991) 1.47

Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med (1999) 1.46

A molecular mechanism for the induction of neurofilament bundling by aluminum ions. J Neurochem (1992) 1.42

Transcription profiles of the bacterium Mycoplasma pneumoniae grown at different temperatures. Nucleic Acids Res (2003) 1.42

Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma--results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol (2001) 1.41

Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Ann Oncol (2010) 1.40

Lead poisoning from the beauty case: neurologic manifestations in an elderly woman. Neurology (2007) 1.40

The 'positive-inside rule' applies to thylakoid membrane proteins. FEBS Lett (1991) 1.40

Training aboriginal health care professionals in Manitoba. CMAJ (2000) 1.39

Senile dementia of Alzheimer type: astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. An immunocytochemical and electron-microscopic study. Acta Neuropathol (1982) 1.38

Nucleotide sequence of the 16S rRNA of Mycoplasma hyopneumoniae. Nucleic Acids Res (1987) 1.37

Organization of the ribosomal RNA genes in Mycoplasma hyopneumoniae: the 5S rRNA gene is separated from the 16S and 23S rRNA genes. Mol Gen Genet (1986) 1.36

Neonatal intracranial hemorrhage in premature infants. Pediatrics (1975) 1.36

Sequence divergence in the ORF6 gene of Mycoplasma pneumonia. J Bacteriol (1994) 1.36

Transcription in Mycoplasma pneumoniae. Nucleic Acids Res (2000) 1.34

Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet (1998) 1.34

Demyelinating neuropathy and monoclonal IgM antibody to myelin-associated glycoprotein. Neurology (1983) 1.33

Surface proteins of Mycoplasma hyopneumoniae identified from an Escherichia coli expression plasmid library. Infect Immun (1985) 1.28

Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis. Eur J Neurol (2009) 1.27

Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes. J Neurol Neurosurg Psychiatry (1986) 1.27

Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland. Acta Neuropathol (1989) 1.27

Identification and complementation of frameshift mutations associated with loss of cytadherence in Mycoplasma pneumoniae. J Bacteriol (1999) 1.27

Identification of gene products of the P1 operon of Mycoplasma pneumoniae. Mol Microbiol (1991) 1.26

Can an endocytoscope system (ECS) predict histology in neoplastic lesions? Endoscopy (2007) 1.25

Analysis of transcription and processing signals of the 16S-23S rRNA operon of Mycoplasma hyopneumoniae. Mol Gen Genet (1986) 1.25

REVIEW: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol Appl Neurobiol (1999) 1.23

The international quality requirements for the conduct of clinical studies and the challenges for study centers to implement them. Ann Oncol (2004) 1.23

Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites. Brain Res (1986) 1.22

Spatial arrangement of gene products of the P1 operon in the membrane of Mycoplasma pneumoniae. Infect Immun (1994) 1.22

Serotonin receptors in the human brain--III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience (1987) 1.22

Localization and biochemical characterization of the ORF6 gene product of the Mycoplasma pneumoniae P1 operon. Infect Immun (1992) 1.22

Dyke Davidoff Masson syndrome with crossed cerebellar atrophy: an old disease in a new millenium. Neuropathol Appl Neurobiol (2001) 1.20

The P200 protein of Mycoplasma pneumoniae shows common features with the cytadherence-associated proteins HMW1 and HMW3. Gene (1996) 1.20

Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera. J Neuroimmunol (1991) 1.20

A randomized phase II trial of capecitabine and two different schedules of irinotecan in first-line treatment of metastatic colorectal cancer: efficacy, quality-of-life and toxicity. Ann Oncol (2005) 1.20

Successful treatment of steroid-refractory neurosarcoidosis with infliximab. J Neurol (2004) 1.19

Distinct Streptococcus thermophilus bacteriophages share an extremely conserved DNA fragment. Virology (1994) 1.19

Axl expression is associated with adverse prognosis and with expression of Bcl-2 and CD34 in de novo acute myeloid leukemia (AML): results from a multicenter trial of the Swiss Group for Clinical Cancer Research (SAKK). Leukemia (1999) 1.19

Defining the mycoplasma 'cytoskeleton': the protein composition of the Triton X-100 insoluble fraction of the bacterium Mycoplasma pneumoniae determined by 2-D gel electrophoresis and mass spectrometry. Microbiology (2001) 1.19

Auditory agnosia and auditory spatial deficits following left hemispheric lesions: evidence for distinct processing pathways. Neuropsychologia (2000) 1.17

Sequence analysis of 56 kb from the genome of the bacterium Mycoplasma pneumoniae comprising the dnaA region, the atp operon and a cluster of ribosomal protein genes. Nucleic Acids Res (1996) 1.17

Laminin alpha2 chain-deficient congenital muscular dystrophy: variable epitope expression in severe and mild cases. Neurology (1998) 1.16

Pick's disease: an immunocytochemical study of neuronal changes. Monoclonal antibodies show that Pick bodies share antigenic determinants with neurofibrillary tangles and neurofilaments. Acta Neuropathol (1983) 1.16

Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol (1993) 1.15

The subunit b of the F0F1-type ATPase of the bacterium Mycoplasma pneumoniae is a lipoprotein. J Biol Chem (1998) 1.15

Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy. Oncology (2003) 1.14

5-Fluorouracil, 4-epidoxorubicin, and mitomycin C (FEM) combination chemotherapy for advanced gastric carcinoma. A phase-II trial by the "chemotherapiegruppe gastrointestinaler tumoren (CGT)". Onkologie (1987) 1.14

Synthesis of a small, cysteine-rich, 29 amino acids long peptide in Mycoplasma pneumoniae. FEMS Microbiol Lett (2005) 1.14

New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol (1989) 1.12

Expression of APP in transgenic mice: a comparison of neuron-specific promoters. Neurobiol Aging (1996) 1.12

The configuration of fibrin clots determines capillary morphogenesis and endothelial cell migration. Microvasc Res (1996) 1.12

Codon reading scheme in Mycoplasma pneumoniae revealed by the analysis of the complete set of tRNA genes. Nucleic Acids Res (1993) 1.12

Biotinidase deficiency: a cause of subacute necrotizing encephalomyelopathy (Leigh syndrome). Report of a case with lethal outcome. Pediatr Res (1989) 1.12

Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS (1992) 1.11

TNF-alpha expression in painful and nonpainful neuropathies. Neurology (2001) 1.11